Revised Geneva Score Calculator

Enter your patient's clinical details — including age, heart rate, prior DVT/PE history, recent surgery or immobilization, active malignancy, unilateral leg pain, hemoptysis, and deep vein tenderness — to calculate the Revised Geneva Score for pulmonary embolism (PE) clinical probability. Your total score is categorized as Low, Intermediate, or High probability, helping guide diagnostic workup decisions. Also try the MCA Calculator (Middle Cerebral Artery).

Disclaimer: This tool is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

Age > 65 years *

Patient age greater than 65 years

Previous DVT or PE *

Previous documented deep vein thrombosis or pulmonary embolism

Surgery or Fracture within 1 Month *

Surgery under general anesthesia or lower-limb fracture within the past month

Active Malignancy *

Solid or hematologic malignancy, currently active or considered cured less than 1 year

Unilateral Lower Limb Pain *

Pain in one leg, not explained by another diagnosis

Hemoptysis *

Coughing up blood

Heart Rate (bpm) *

Patient's heart rate in beats per minute

Pain on Deep Palpation of Lower Limb and Unilateral Edema *

Pain on deep venous palpation of the lower limb AND unilateral edema

Results

Revised Geneva Score

--

PE Probability

--

Estimated PE Prevalence

--

Clinical Guidance

--

Results Table

Frequently Asked Questions

What is the Revised Geneva Score used for?

The Revised Geneva Score (rGeneva) is a validated clinical decision tool used to estimate the pre-test probability of pulmonary embolism (PE) in adult patients presenting with suspected PE. It helps clinicians decide whether to proceed with imaging (e.g., CT pulmonary angiography) or D-dimer testing based on the calculated risk category. See also our calculate HAS-BLED.

How is the Revised Geneva Score interpreted?

Scores of 0–3 indicate Low probability (PE prevalence ~8%), scores of 4–10 indicate Intermediate probability (PE prevalence ~28%), and scores ≥11 indicate High probability (PE prevalence ~74%). Higher scores warrant more urgent diagnostic workup.

What is the difference between the original Geneva Score and the Revised Geneva Score?

The original Geneva Score included arterial blood gas values, which require an invasive test. The Revised Geneva Score (2006) replaced these with clinical and readily available variables — such as heart rate, leg pain, and hemoptysis — making it easier to apply at the bedside without laboratory tests.

How does the Revised Geneva Score compare to the Wells PE Score?

Both tools stratify PE probability but differ in variables used. The Wells score includes a subjective 'alternative diagnosis less likely than PE' criterion, while the Revised Geneva Score is fully objective. Studies show both have similar diagnostic accuracy; the rGeneva is preferred when a more objective, reproducible tool is needed.

Can the Revised Geneva Score be used alone to rule out PE?

No. A low Revised Geneva Score should be combined with a D-dimer test. If the score is low and D-dimer is negative, PE can generally be ruled out without imaging. Intermediate or high scores typically require CT pulmonary angiography (CTPA) for definitive diagnosis.

Is the Revised Geneva Score validated in all patient populations?

The Revised Geneva Score has been validated primarily in adult outpatient and emergency department populations with suspected PE. It is not validated for use in pediatric patients, pregnant patients, or those already on therapeutic anticoagulation. Clinical judgment should always supplement the score.

What score range qualifies as high probability for PE?

A Revised Geneva Score of 11 or greater is classified as High probability for pulmonary embolism. In this group, studies estimate the PE prevalence to be approximately 74%, and immediate diagnostic imaging with CTPA or ventilation-perfusion (V/Q) scanning is strongly recommended.

Does heart rate significantly affect the Revised Geneva Score?

Yes. Heart rate is one of the most heavily weighted variables. A heart rate of 75–94 bpm adds 3 points, and a rate ≥95 bpm adds 5 points. Because tachycardia is a common physiological response to PE, its inclusion improves the score's sensitivity for detecting higher-risk patients.